Found: 23
Select item for more details and to access through your institution.
The Development of a Novel Cancer Immunotherapeutic Platform Using Tumor-targeting Mesenchymal Stem Cells and a Protein Vaccine.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2249, doi. 10.1038/mt.2011.152
- By:
- Publication type:
- Article
Gene Therapy for SCID-X1: Focus on Clinical Data.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2258, doi. 10.1038/mt.2011.167
- By:
- Publication type:
- Article
Microarray Analysis of Gene Expression Profiles in Cells Transfected With Nonviral Vectors.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2144, doi. 10.1038/mt.2011.161
- By:
- Publication type:
- Article
Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2186, doi. 10.1038/mt.2011.190
- By:
- Publication type:
- Article
ATP7A Gene Addition to the Choroid Plexus Results in Long-term Rescue of the Lethal Copper Transport Defect in a Menkes Disease Mouse Model.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2114, doi. 10.1038/mt.2011.143
- By:
- Publication type:
- Article
Rational Design of Therapeutic siRNAs: Minimizing Off-targeting Potential to Improve the Safety of RNAi Therapy for Huntington's Disease.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2169, doi. 10.1038/mt.2011.185
- By:
- Publication type:
- Article
Systemic Administration of Combinatorial dsiRNAs via Nanoparticles Efficiently Suppresses HIV-1 Infection in Humanized Mice.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2228, doi. 10.1038/mt.2011.207
- By:
- Publication type:
- Article
Gene Transfer Using HACs: A Key Step Closer to Ex Vivo Gene Therapy Using Autologous Gene-Corrected Cells to Treat Muscular Dystrophy.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
Stabilization of Expanded (CTG)•(CAG) Repeats by Antisense Oligonucleotides.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2222, doi. 10.1038/mt.2011.191
- By:
- Publication type:
- Article
Research Highlights.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2107, doi. 10.1038/mt.2011.247
- Publication type:
- Article
Efficient In Vivo Delivery of siRNA Into Brain Capillary Endothelial Cells Along With Endogenous Lipoprotein.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2213, doi. 10.1038/mt.2011.186
- By:
- Publication type:
- Article
Combining mTor Inhibitors With Rapamycin-resistant T Cells: A Two-pronged Approach to Tumor Elimination.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2239, doi. 10.1038/mt.2011.179
- By:
- Publication type:
- Article
Phase Ia Clinical Evaluation of the Plasmodium falciparum Blood-stage Antigen MSP1 in ChAd63 and MVA Vaccine Vectors.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2269, doi. 10.1038/mt.2011.176
- By:
- Publication type:
- Article
Uptake, Efficacy, and Systemic Distribution of Naked, Inhaled Short Interfering RNA (siRNA) and Locked Nucleic Acid (LNA) Antisense.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2163, doi. 10.1038/mt.2011.206
- By:
- Publication type:
- Article
PiggyBac-mediated Cancer Immunotherapy Using EBV-specific Cytotoxic T-cells Expressing HER2-specific Chimeric Antigen Receptor.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2133, doi. 10.1038/mt.2011.131
- By:
- Publication type:
- Article
Interfering With Tumor Pathways That Augment Viral Oncolysis.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
lncRNAs: Finding the Forest Among the Trees?
- Published in:
- 2011
- By:
- Publication type:
- Opinion
Selective Therapeutic Targeting of the Anaplastic Lymphoma Kinase With Liposomal siRNA Induces Apoptosis and Inhibits Angiogenesis in Neuroblastoma.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2201, doi. 10.1038/mt.2011.142
- By:
- Publication type:
- Article
Co-operative Membrane Disruption Between Cell-penetrating Peptide and Cargo: Implications for the Therapeutic Use of the Bcl-2 Converter Peptide D-NuBCP-9-r8.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2124, doi. 10.1038/mt.2011.175
- By:
- Publication type:
- Article
Potent and Selective Antisense Oligonucleotides Targeting Single-Nucleotide Polymorphisms in the Huntington Disease Gene / Allele-Specific Silencing of Mutant Huntingtin.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2178, doi. 10.1038/mt.2011.201
- By:
- Publication type:
- Article
In This Issue.
- Published in:
- 2011
- Publication type:
- Abstract
Preclinical Safety of RNAi-Mediated HTT Suppression in the Rhesus Macaque as a Potential Therapy for Huntington's Disease.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2152, doi. 10.1038/mt.2011.219
- By:
- Publication type:
- Article